AlphaCrest Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,556	Closed	-$405K	–	1231
2021 Q4	$405K	Buy	+8,556	New	+$405K	0.02%	1169
2021 Q2	–	Sell	-18,500	Closed	-$794K	–	1215
2021 Q1	$794K	Buy	18,500 +10,400	+128%	+$446K	0.04%	595
2020 Q4	$463K	Buy	+8,100	New	+$463K	0.04%	692